Avalon GloboCare details debenture conversions

Avalon GloboCare Corp. filed a current report to share information it released in a press release dated February 2, 2026.

Accepted by SEC EDGAR 02/02/2026 - 09:00 AM EST

Filing Impact

(High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Avalon GloboCare Corp. filed a current report to share information it released in a press release dated February 2, 2026. The company announced the conversion of the majority of its outstanding debentures, indicating a significant change in how this debt is structured. The press release describing this conversion is attached as an exhibit and is treated as furnished under Regulation FD rather than filed under the securities laws.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Avalon GloboCare (ALBT) announce in its February 2, 2026 8-K?

Avalon GloboCare announced that the majority of its outstanding debentures have been converted. This information was shared through a press release dated February 2, 2026, which is attached to the report as Exhibit 99.1 and incorporated by reference.

Which item of Form 8-K did Avalon GloboCare use for this debenture update?

Avalon GloboCare used Item 7.01, Regulation FD Disclosure, for this update. This means the company is furnishing the press release to provide broad, fair disclosure of the debenture conversion information rather than treating it as filed for liability purposes.

How is the Avalon GloboCare debenture conversion information treated under securities laws?

The debenture conversion information, including Exhibit 99.1, is furnished under Regulation FD and not deemed filed under Section 18 of the Exchange Act. It is also not automatically incorporated into other Securities Act or Exchange Act filings unless specifically referenced.

What exhibit did Avalon GloboCare attach regarding the debenture conversion?

Avalon GloboCare attached Exhibit 99.1, a press release dated February 2, 2026 describing the conversion of the majority of its outstanding debentures. It also included Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.

Who signed Avalon GloboCare’s February 2, 2026 8-K about debenture conversions?

The 8-K was signed on behalf of Avalon GloboCare by Luisa Ingargiola, its Chief Financial Officer. Her signature indicates she was the duly authorized officer executing the report dated February 2, 2026 describing the debenture conversion press release.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): February 2, 2026

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

Delaware	001-38728	47-1685128
(State or other jurisdiction	(Commission File Number)	(I.R.S. Employer
of incorporation)		Identification Number)

4400 Route 9 South, Suite 3100, Freehold, NJ 07728

(Address of principal executive offices)

(732) 780-4400

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ALBT		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

On February 2, 2026, Avalon GloboCare Corp. (the “Company”) issued a press release announcing the conversion of the majority of its outstanding debentures.

The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information included in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth under this Item 7.01 shall not be deemed an admission as to the materiality of any information contained herein that is required to be disclosed solely to satisfy the requirements of Regulation FD.

Item 9.01. Financial Statement and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press release of the registrant dated February 2, 2026.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AVALON GLOBOCARE CORP.

Dated: February 2, 2026	By:	/s/ Luisa Ingargiola
	Name:	Luisa Ingargiola
	Title:	Chief Financial Officer

Source: View Original Filing on SEC EDGAR